Chapter title |
Computer-Aided Drug Discovery and Design: Recent Advances and Future Prospects.
|
---|---|
Book title |
Computational Drug Discovery and Design
|
Published in |
Methods in molecular biology, January 2024
|
DOI | 10.1007/978-1-0716-3441-7_1 |
Pubmed ID | |
Book ISBNs |
978-1-07-163440-0, 978-1-07-163441-7
|
Authors |
Talevi, Alan |
Abstract |
Computer-aided drug discovery and design involve the use of information technologies to identify and develop, on a rational ground, chemical compounds that align a set of desired physicochemical and biological properties. In its most common form, it involves the identification and/or modification of an active scaffold (or the combination of known active scaffolds), although de novo drug design from scratch is also possible. Traditionally, the drug discovery and design processes have focused on the molecular determinants of the interactions between drug candidates and their known or intended pharmacological target(s). Nevertheless, in modern times, drug discovery and design are conceived as a particularly complex multiparameter optimization task, due to the complicated, often conflicting, property requirements.This chapter provides an updated overview of in silico approaches for identifying active scaffolds and guiding the subsequent optimization process. Recent groundbreaking advances in the field have also analyzed the integration of state-of-the-art machine learning approaches in every step of the drug discovery process (from prediction of target structure to customized molecular docking scoring functions), integration of multilevel omics data, and the use of a diversity of computational approaches to assist target validation and assess plausible binding pockets. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 17 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 1 | 6% |
Other | 1 | 6% |
Lecturer | 1 | 6% |
Professor | 1 | 6% |
Student > Ph. D. Student | 1 | 6% |
Other | 1 | 6% |
Unknown | 11 | 65% |
Readers by discipline | Count | As % |
---|---|---|
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 18% |
Biochemistry, Genetics and Molecular Biology | 1 | 6% |
Computer Science | 1 | 6% |
Neuroscience | 1 | 6% |
Chemistry | 1 | 6% |
Other | 0 | 0% |
Unknown | 10 | 59% |